Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA

Lancet Infect Dis. 2017 Oct;17(10):e327-e333. doi: 10.1016/S1473-3099(17)30248-7. Epub 2017 May 8.

Abstract

Since 1989, the USA has been pursuing the goal of tuberculosis elimination. After substantial progress during the past two decades, the rate of tuberculosis cases in the USA each year has now levelled off and remains well above the elimination threshold. Both epidemiological data and modelling underline the necessity of addressing latent tuberculosis infection if further progress is to be made in eliminating the disease. In this Personal View we explore next steps towards elimination. Given the estimated prevalence of latent tuberculosis infection, compared with the limited testing and treatment that currently occur, a major new effort is required. This effort should consist of a surveillance system or registry to monitor progress, scale-up of targeted testing for latent tuberculosis infection in at-risk populations, scale-up of short-course treatment regimens, engagement of affected communities and medical providers who serve those communities, and increased public health staffing for implementation and oversight. Such an effort would benefit greatly from the development of new tools, such as tests that better indicate reactivation risk, and even shorter latent tuberculosis infection treatment regimens than currently exist.

Publication types

  • Review

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Humans
  • Latent Tuberculosis / diagnosis
  • Latent Tuberculosis / drug therapy
  • Latent Tuberculosis / epidemiology*
  • Time Factors
  • Tuberculosis / epidemiology*
  • Tuberculosis / pathology*
  • United States / epidemiology

Substances

  • Antitubercular Agents